IHAM
ILMN icon

Integral Health Asset Management’s Illumina ILMN Stock Holding History

Integral Health Asset Management’s Portfolio ILMN Stock Details ILMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,000
Closed -$5.35M – 93
2024
Q4 		$5.35M Buy
+40,000
New +$5.7M 0.46% 61
2024
Q1 		– Sell
-51,400
Closed -$6.96M – 88
2023
Q4 		$6.96M Buy
+51,400
New +$5.93M 0.95% 48
2022
Q4 		– Sell
-30,840
Closed -$5.72M – 78
2022
Q3 		$5.72M Buy
+30,840
New +$6.1M 1.11% 39

Other funds holding ILMN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Integral Health Asset Management's ILMN Position: Q1 2025 in Review

Integral Health Asset Management sold out of Illumina (ILMN) in Q1 2025, closing a stake of 40,000 shares — an estimated $5.35M sold.

Integral Health Asset Management first reported a position in ILMN in Q3 2022 and held it in 3 quarters. The position peaked at $6.96M in Q4 2023. 721 funds tracked by Wall St. Rank hold ILMN as of Q1 2025.

  • Integral Health Asset Management reported no remaining Illumina position as of Q1 2025 after selling out during the quarter.
  • Integral Health Asset Management sold 40,000 Illumina shares in Q1 2025, an estimated $5.35M.
  • Integral Health Asset Management first reported a position in Illumina in Q3 2022 and held it in 3 quarters.
  • Integral Health Asset Management's Illumina position peaked at $6.96M in Q4 2023.
  • 721 funds tracked by Wall St. Rank held Illumina as of Q1 2025.

Based on Integral Health Asset Management's 13F filing for Q1 2025, filed 15 May 2025.